Interested in ordering geneType™?
Learn more about our breast cancer test with this video featuring Dr. Carolynn Young and Dr. Joel Evans discussing factors that influence breast cancer risk and the clinical utility of geneType™ for Breast Cancer on The Balancing Act.
Develop your own personalised preventative pathway with a healthcare professional. Designed for those who know their family history and want to further understand their disease risk.
Get a further understanding of disease risk.
geneType™ Integrated Risk, Polygenic Risk (PRS) and Clinical Risk (CRS)*
*Tests can only be ordered by medical practitioners
Inherited Monogenic Disease (Germline)
Speak to your medical practitioner about whether this test is right for you
The simple act of knowing whether you are at increased risk of developing breast cancer may be enough to change the course of your life.
geneType™ for Breast Cancer looks beyond family history, it combines familial, genetic and clinical risk factors to provide you with a more comprehensive risk profile.¹
With this information, you and your healthcare professional can then develop a personalised preventive health plan – that may change the course of your life.
Knowing your personalised risk enables you to develop a health plan with your healthcare professional to reduce your risk of serious disease. Select from the tests below to take the first step to managing your risk
Find out if you are at increased risk of developing breast cancer
Find out if you are at increased risk of developing bowel (colorectal) cancer
Find out if you are at increased risk of developing ovarian cancer
Find out if you are at increased risk of developing prostate cancer
Find out if you are at increased risk of developing artery disease
Find out if you are at increased risk of developing type 2 diabetes
Find out if you are at increased risk of developing a wide range of cancers as well as heart disease and type 2 diabetes
geneType™ provides lifetime and 10-year risk scores for pancreatic cancer
geneType™ provides lifetime and 10-year risk scores for melanoma
geneType™ provides a 10-year risk score for atrial fibrillation
Our expert scientific team has dedicated the last 20 years to translating research into validated clinical tests with actionable outcomes for patients.
Our extensive range of patents, peer-reviewed publications and validated tests reflects this commitment to making personalised, predictive healthcare a reality.
